Search results
Is Merck Stock Fully Valued At $130?
Forbes· 17 hours agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 6 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 6 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 6 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 6 days agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 6 days agoIn Diabetes, Januvia/Janumet (diabetes) franchise sales declined 21% year over year to $670 million....
Guide for Newly Diagnosed Diabetes: How to Make a Plan
Healthline· 7 days agoReceiving a diabetes diagnosis can feel overwhelming at first. Learning more about diabetes care —...
May 1, 2024, Letters to the Editor
The Record-Courier· 15 hours agoZephyr Cove Resort previously leased from the Forest Service about a half mile of lakefront. Despite public objections, the Forest Service has now agreed...
Cantor Fitzgerald Brokers Boost Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 2 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for shares of Merck & Co., Inc. in a research ...
